[go: up one dir, main page]

Keter, 2004 - Google Patents

Pyrazole and pyrazolyl palladium (II) and platinum (II) complexes: synthesis and in vitro evaluation as anticancer agents

Keter, 2004

View PDF
Document ID
6280919808176773804
Author
Keter F
Publication year

External Links

Snippet

The use of metallo-pharmaceuticals, such as the platinum drugs, for cancer treatment illustrates the utility of metal complexes as therapeutic agents. Platinum group metal complexes therefore offer potential as anti-tumour agents to fight cancer. This study was …
Continue reading at uwcscholar.uwc.ac.za (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0073—Rhodium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F17/00—Metallocenes
    • C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P-C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/002—Osmium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
    • C07F15/0033—Iridium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals

Similar Documents

Publication Publication Date Title
Singh et al. Design, synthesis, characterization, and antiproliferative activity of organoplatinum compounds bearing a 1, 2, 3-triazole ring
Khan et al. Synthesis, characterization and anticancer studies of mixed ligand dithiocarbamate palladium (II) complexes
Devi et al. Synthesis, interaction with DNA, cytotoxicity, cell cycle arrest and apoptotic inducing properties of ruthenium (II) molecular “light switch” complexes
Peacock et al. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N, O-chelating ligands to achieve cancer cell cytotoxicity
Mu et al. Activation by oxidation: ferrocene-functionalized Ru (II)-arene complexes with anticancer, antibacterial, and antioxidant properties
Casini et al. Molecular mechanisms and proposed targets for selected anticancer gold compounds
Pérez et al. New acridine thiourea gold (I) anticancer agents: Targeting the nucleus and inhibiting vasculogenic mimicry
Kovala-Demertzi et al. Platinum (II) complexes with 2-acetyl pyridine thiosemicarbazone: synthesis, crystal structure, spectral properties, antimicrobial and antitumour activity
Jeyalakshmi et al. Coordination behavior of N, N′, N ″-trisubstituted guanidine ligands in their Ru–arene complexes: synthetic, DNA/protein binding, and cytotoxic studies
Warad et al. Metal ions as antitumor complexes-Review
Rafols et al. Piano-stool ruthenium (II) complexes with delayed cytotoxic activity: Origin of the lag time
Leyva et al. Synthesis of cycloruthenated compounds as potential anticancer agents
Ribeiro et al. Ruthenium (II) phosphine/mercapto complexes: their in vitro cytotoxicity evaluation and actions as inhibitors of topoisomerase and proteasome acting as possible triggers of cell death induction
Tikum et al. Cytotoxic and anticancer properties of new ruthenium polypyridyl complexes with different lipophilicities
Schwarzbich et al. Stronger cytotoxicity for cancer cells than for fast proliferating human stem cells by rationally designed dinuclear complexes
Renfrew et al. Use of perfluorinated phosphines to provide thermomorphic anticancer complexes for heat-based tumor targeting
Lord et al. Rhodium (III) dihalido complexes: the effect of ligand substitution and halido coordination on increasing cancer cell potency
Ni et al. Exploring anticancer activities and structure–activity relationships of binuclear oxidovanadium (IV) complexes
Montaña et al. Synthesis, characterization and antiproliferative studies of the enantiomers of cis-[(1, 2-camphordiamine) dichloro] platinum (II) complexes
Chen et al. Ruthenium (ii) arene complexes showing DNA photobinding: the role of the basicity of the monodentate ligand
Keter Pyrazole and pyrazolyl palladium (II) and platinum (II) complexes: synthesis and in vitro evaluation as anticancer agents
Singh et al. Isomeric platinum organometallics derived from pyrimidine, pyridazine or pyrazine and their potential as antitumor drugs
Nazari et al. Vanadium complexes with maltol and deferiprone ligands: synthesis, characterization and in vitro antiproliferative activity toward different cancer cells
Bologna et al. Water-soluble platinum phthalocyanines as potential antitumor agents
Zou Anti-Cancer N-Heterocyclic Carbene Complexes of Gold (III), Gold (I) and Platinum (II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase Inhibitors and Endoplasmic Reticulum Targeting Agents